Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 19 of 19 for “"Cell line engineering"”.
-
Bioprocess and cell line engineering to improve pancreatic endocrine differentiation outcomes and increase safety of pluripotent stem cells
… by chronic hyperglycemia caused by pancreatic β-cell dysfunction or death. Those that are affected need to frequently monitor their blood glucose levels and administer exogenous insulin, but this strategy does not match the tight regulation maintained by healthy β-cells. Progress in the field has …
-
Profiling the landscape of long non- coding RNAs in the Chinese hamster ovary cell transcriptome
Chinese hamster ovary (CHO) cells are the most commonly used cell line for the production of recombinant proteins in the pharmaceutical industry. Next generation sequencing (NGS) experiments have produced Cricetulus griseus and CHO genomic and transcriptomic references that have expanded the …
-
Metabolic Engineering and Process Development Approaches to Enhance Biotherapeutics Production from Mammalian Cells
Mammalian cells especially Chinese Hamster Ovary (CHO) cells have been the dominating production platforms for monoclonal antibodies (mAbs) and other glycoproteins. Improving their productivity and product quality through cell line engineering and media optimization is the major focus of the …
-
The application and validation of high-throughput methods in Chinese hamster ovary cell line development
Chinese hamster ovary (CHO) cells are the main production platform for biotherapeutic proteins. In this thesis, two areas were identified and investigated with improving recombinant protein production from CHO cells and cell line development; transcriptomics and technologies for industrial cell …
-
MOLECULAR ROLES OF HSP27 IN IMPROVING MONOCLONAL ANTIBODY PRODUCTION OF CHO CELLS
CHO CELLS ARE THE MAMMALIAN CELL LINES OF CHOICE FOR THE PRODUCTION OF RECOMBINANT THERAPEUTIC BIOLOGICS INCLUDING THE RAPIDLY EXPANDING MONOCLONAL ANTIBODIES (MAB) AND BIOSIMILARS. THERE ARE OPPORTUNITIES TO EXPLORE THE USE OF ENGINEERED CHO CELL LINES WITH IMPROVED RECOMBINANT BIOLOGICS …
-
Essays on CHO: An Investigation of Industrially Relevant Stressors in Recombinant Protein Production
… are produced in Chinese hamster ovary (CHO) cells due to their well-established expression systems, scalability, and ability to produce safe, human-compatible glycoproteins. Previous research has aimed to increase productivity while maintaining or improving product quality metrics, resulting …
-
SELECTION EFFECT BIAS INTRODUCED BY ANTIBIOTIC RESISTANCE MARKERS IN TRANSGENIC MAMMALIAN CELL SELECTION
Transgenic mammalian cells are typically isolated by co-delivery of a transgene and a selectable marker gene, followed by treatment with conditions that eliminate non-transgenic cells. These include antibiotic resistance (AR) genes with antibiotic selection (e.g., PuroR/puromycin), metabolic enzyme …
-
Profiling the dynamic changes in the phosphoproteome of Chinese hamster ovary cells
… plays a pivotal role in regulating vital cellular processes. Despite the importance of the phosphorylation level of regulation, little work has been carried out on the phosphoproteomic characterization of Chinese hamster ovary (CHO) cells in bioprocess-relevant conditions. To bridge this …
-
Engineering of the Secretory Pathway of CHO Cells for Recombinant Protein Production: Manipulation of SNARE Proteins
… achieved at an industrial scale using cultured cell systems with a number of host systems used including bacteria, yeast, insect cells and mammalian cells, depending on the needs of the protein to be produced. In the last 2-3 decades, the market for recombinant protein production has been …
-
Engineering Chinese Hamster Ovary cell recombinant protein glycosylation
… is the genetic differences in the host cell lines used to manufacture these biologics. Many biologics approved before 2011 were expressed in murine cell lines, whereas Chinese Hamster Ovary (CHO) cells have become the preferred hosts for production. Differences between glycosylation have …
-
A synthetic approach to produce recombinant adeno-associated virus (rAAV) in Chinese hamster ovary (CHO) cells
… are relying on transiently transfecting host cells with three plasmids or infection of producer cell lines with helper viruses. Both methods pose real issues in process development, such as difficulty to scale-up or cleaning up helper virus from final products. Commonly used host cell lines …
-
Rewiring the Cell Factory: Engineering Strategies to Alter Cell Behavior and Productivity for Biomanufacturing Systems
… more efficient and economically viable mammalian cell biomanufacturing processes. Despite advances in process development, manufacturing remains a major barrier to the widespread availability of many biologics, particularly recombinant adeno-associated virus (rAAV) vectors for gene therapy. …
-
Development of a Tunable Mammalian Protein Expression System and an Investigation of Promoter Interference in Three Promoters Often Utilized in the Production of Biopharmaceuticals
Cell line engineering strategies for improved biopharmaceutical production in mammalian cells often involve the expression of one/multiple genes to try and improve the cellular processes involved in recombinant protein production. Most strategies are relatively simple, involving the use of a strong …
-
UNRAVELING CHO METABOLIC PROCESSES USING STABLE ISOTOPE LABELING TO ENHANCE BIOPROCESS PERFORMANCE
Chinese Hamster Ovary (CHO) cells are the preferred host systems for recombinant protein therapeutics production including monoclonal antibodies and fusion proteins. CHO cells have the ability to grow in high densities in suspension and produce glycosylation patterns that are compatible with …